Inhaled corticosteroids and the risk of type 2 diabetes among Swedish COPD patients

This study reports the association of ICS use and the risk of type 2 diabetes mellitus (T2DM) in Swedish patients with COPD using data from real-world, primary care settings. A total of 7078 patients with COPD were included in this analysis and the 5-year cumulative incidence rate per 100,000 person...

Descripción completa

Detalles Bibliográficos
Autores principales: Ställberg, Björn, Janson, Christer, Lisspers, Karin, Johansson, Gunnar, Gutzwiller, Florian S., Mezzi, Karen, Bjerregaard, Bine Kjoeller, Kejs, Anne Mette Tranberg, Jorgensen, Leif, Larsson, Kjell
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576803/
https://www.ncbi.nlm.nih.gov/pubmed/33082331
http://dx.doi.org/10.1038/s41533-020-00207-7
Descripción
Sumario:This study reports the association of ICS use and the risk of type 2 diabetes mellitus (T2DM) in Swedish patients with COPD using data from real-world, primary care settings. A total of 7078 patients with COPD were included in this analysis and the 5-year cumulative incidence rate per 100,000 person years was 1506.9. The yearly incidence rate per 100,000 person years ranged from 850 to 1919. Use of ICS especially at a high dose in patients with COPD was related to an increased risk of T2DM.

Ejemplares similares